Evolution of drug-resistant hepatitis C virus clones during direct-acting antiviral therapy.
Source: NCBI BioProject (ID PRJDB5184)
Source: NCBI BioProject (ID PRJDB5184)
0 0
Project name: Hepacivirus C
Description: Hepatitis C virus (HCV) resistance-associated variants are associated with treatment failure in HCV-infected patients receiving direct-acting antivirals (DAAs). We evaluated the clonal origin and dynamics of resistance-associated variants in patients undergoing DAA therapy.
Data type: Targeted Locus (Loci)
Sample scope: Multiisolate
Relevance: Medical
Organization: Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University
Release date: 2018-03-30
Last updated: 2016-09-23